相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis
Cristina Mosconi et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2021)
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
Angela Lamarca et al.
LANCET ONCOLOGY (2021)
Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents
Fasiha Kanwal et al.
HEPATOLOGY (2020)
Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium
Helena Degroote et al.
SURGICAL ONCOLOGY-OXFORD (2020)
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial
Alice Markussen et al.
CANCERS (2020)
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
John N. Primrose et al.
LANCET ONCOLOGY (2019)
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores
George N. Ioannou et al.
GASTROENTEROLOGY (2019)
A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma
Yanhua Zhen et al.
ONCOTARGETS AND THERAPY (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis
Laura Kulik et al.
HEPATOLOGY (2018)
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
Kristina Tzartzeva et al.
GASTROENTEROLOGY (2018)
Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study
Cassia Regina Guedes Leal et al.
INVESTIGATIONAL NEW DRUGS (2018)
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K. H. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Systematic Review and Meta-Analysis of Posttransplant Hepatic Artery and Biliary Complications in Patients Treated With Transarterial Chemoembolization Before Liver Transplantation
Dimitri Sneiders et al.
TRANSPLANTATION (2018)
Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: Systematic review and meta-analysis
Diogo Turiani Hourneaux De Moura et al.
ENDOSCOPIC ULTRASOUND (2018)
Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial
Jianfeng Yang et al.
ENDOSCOPY (2018)
Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Byeong G. Song et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal et al.
GASTROENTEROLOGY (2018)
Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma
Kei Endo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials
Andrea Casadei Gardini et al.
ONCOTARGETS AND THERAPY (2018)
Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma
Johannes M. Ludwig et al.
EUROPEAN RADIOLOGY (2017)
Impact of preoperative locoregional therapy on recurrence and patient survival following liver transplantation for hepatocellular carcinoma: a meta-analysis
Xinli Huang et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies
Francesca Bravi et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2017)
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma
David J. Pinato et al.
JOURNAL OF HEPATOLOGY (2017)
Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B score
W. P. Brouwer et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis
Yuenan Huang et al.
ONCOTARGET (2017)
Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
Jason C. Simeone et al.
CLINICAL EPIDEMIOLOGY (2017)
Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis
Nicha Wongjarupong et al.
BMC GASTROENTEROLOGY (2017)
Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma
K. K. C. Ng et al.
BRITISH JOURNAL OF SURGERY (2017)
Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study
Tom M. Ganten et al.
CLINICAL CANCER RESEARCH (2017)
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Tim Meyer et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria
H. Liu et al.
BRITISH JOURNAL OF SURGERY (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
Jorge A. Marrero et al.
JOURNAL OF HEPATOLOGY (2016)
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
Riccardo Lencioni et al.
JOURNAL OF HEPATOLOGY (2016)
Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis
Elena Raffetti et al.
LIVER INTERNATIONAL (2016)
Referral Criteria for Outpatient Palliative Cancer Care: A Systematic Review
David Hui et al.
ONCOLOGIST (2016)
Early Palliative Care in Advanced Oncologic and Non-Oncologic Chronic Diseases: A Systematic Review of Literature
Davide Tassinari et al.
REVIEWS ON RECENT CLINICAL TRIALS (2016)
The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition
Krasimira Aleksandrova et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Association of Coffee Intake With Reduced Incidence of Liver Cancer and Death From Chronic Liver Disease in the US Multiethnic Cohort
Veronica Wendy Setiawan et al.
GASTROENTEROLOGY (2015)
Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review
Udayakumar Navaneethan et al.
GASTROINTESTINAL ENDOSCOPY (2015)
Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors
Sadahisa Ogasawara et al.
INVESTIGATIONAL NEW DRUGS (2015)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: A randomized trial
Giovan Giuseppe Di Costanzo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
Downstaging hepatocellular carcinoma: A systematic review and pooled analysis
Neehar D. Parikh et al.
LIVER TRANSPLANTATION (2015)
Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
Joon Oh Park et al.
CANCER RESEARCH AND TREATMENT (2015)
Integration of Oncology and Palliative Care: A Systematic Review
David Hui et al.
ONCOLOGIST (2015)
Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer
V. Nagaraja et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials
J. W. Valle et al.
ANNALS OF ONCOLOGY (2014)
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
R. Golfieri et al.
BRITISH JOURNAL OF CANCER (2014)
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma
Alessandro Cucchetti et al.
DIGESTIVE AND LIVER DISEASE (2014)
Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
Thomas Yau et al.
GASTROENTEROLOGY (2014)
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
Lei Yin et al.
JOURNAL OF HEPATOLOGY (2014)
Early integration of palliative care in hospitals: A systematic review on methods, barriers, and outcome
Karen Marie Dalgaard et al.
PALLIATIVE & SUPPORTIVE CARE (2014)
Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography - a randomised study
C. Pocha et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
T. Pressiani et al.
ANNALS OF ONCOLOGY (2013)
Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging
Michele Di Martino et al.
EUROPEAN RADIOLOGY (2013)
Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
Zhen-Wei Peng et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Evaluation of the seventh edition of the American Joint Committee on Cancer tumournodemetastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system
Albert C. Y. Chan et al.
HPB (2013)
Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis
Wei Jing et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2012)
Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
Sarwa Darwish Murad et al.
GASTROENTEROLOGY (2012)
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
Kai Feng et al.
JOURNAL OF HEPATOLOGY (2012)
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
William C. Palmer et al.
JOURNAL OF HEPATOLOGY (2012)
Ultrasonographic Surveillance of Hepatocellular Carcinoma in Cirrhosis: A Randomized Trial Comparing 3-and 6-Month Periodicities
Jean-Claude Trinchet et al.
HEPATOLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Risk of cancer in a large cohort of U.S. veterans with diabetes
Elizabeth A. Atchison et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: An analysis of diagnostic performance and resource utilization
Korosh Khalili et al.
JOURNAL OF HEPATOLOGY (2011)
Additional Value of Gadoxetic Acid-DTPA-Enhanced Hepatobiliary Phase MR Imaging in the Diagnosis of Early-Stage Hepatocellular Carcinoma: Comparison With Dynamic Triple-Phase Multidetector CT Imaging
Hiroki Haradome et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2011)
A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria
Jiwei Huang et al.
ANNALS OF SURGERY (2010)
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
T. Okusaka et al.
BRITISH JOURNAL OF CANCER (2010)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Risk of Hepatobiliary and Pancreatic Cancers After Hepatitis C Virus Infection: A Population-Based Study of US Veterans
Hashem B. El-Serag et al.
HEPATOLOGY (2009)
Long-term follow up of gallbladder polyps
Jeong Youp Park et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Validation of the BCLC Prognostic System in Surgical Hepatocellular Cancer Patients
A. Vitale et al.
TRANSPLANTATION PROCEEDINGS (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Validation of a New Prognostic Staging System for Hepatocellular Carcinoma: A Comparison of the Biomarker-Combined Japan Integrated Staging Score, the Conventional Japan Integrated Staging Score and the BALAD Score
Satoshi Kitai et al.
ONCOLOGY (2008)
Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period
Natasha S. Becker et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
Vincenzo Mazzaferro et al.
HEPATOLOGY (2006)
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
MS Chen et al.
ANNALS OF SURGERY (2006)
Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort
JA Marrero et al.
HEPATOLOGY (2005)
Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: A prospective study in Japan
M Inoue et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Randomized controlled trial of screening for hepatocellular carcinoma
BH Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the Liver Italian Program staging system - A study based on 926 patients
TWT Leung et al.
CANCER (2002)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
T Takayama et al.
LANCET (2000)
分享论文
